Clinical management of ascites and its complications (Q34374968)

1 August 2017

1 reference

title

Clinical management of ascites and its complications (English)

1 reference

1 August 2017

Wongcharatrawee S

1

1 reference

1 August 2017

Garcia-Tsao G

series ordinal

2

1 reference

1 August 2017

language of work or name

1 reference

1 August 2001

1 reference

1 August 2017

published in

Clinics in liver disease

1 reference

1 August 2017

volume

5

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

833-850

1 reference

Vasodilatation and sodium retention in prehepatic portal hypertension

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Acute hemoperitoneum after large-volume paracentesis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Prognostic value of spontaneous hyponatremia in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Epidemiology of Severe Hospital‐Acquired Infections in Patients with Liver Cirrhosis: Effect of Long‐Term Administration of Norfloxacin

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Diuresis in the ascitic patient: a randomized controlled trial of three regimens

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Polymorphonuclear cell count response and duration of antibiotic therapy in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Management of ascites and renal failure in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Complications of transjugular intrahepatic portosystemic shunt: a comprehensive review

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Further evidence against the use of aminoglycosides in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Pharmacotherapy of ascites associated with cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Paracentesis with Intravenous Infusion of Albumin as Compared with Peritoneovenous Shunting in Cirrhosis with Refractory Ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Hyponatremia in cirrhosis: from pathogenesis to treatment

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Complications after peritoneovenous shunting for ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: Effects on renal function and vasoactive systems

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

The Effect of Ciprofloxacin in the Prevention of Bacterial Infection in Patients With Cirrhosis After Upper Gastrointestinal Bleeding

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

The effect of large volume paracentesis on plasma volume--a cause of hypovolemia?

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Effect of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites?

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Single, total paracentesis for tense ascites: sequential hemodynamic changes and right atrial size

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Paracentesis-induced circulatory dysfunction: Mechanism and effect on hepatic hemodynamics in cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function.

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Effect of portosystemic shunting on PGI2 and glucagon levels in humans

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Pattern of sodium handling and its consequences in patients with preascitic cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

Signed consent for publication

1 reference

https://api.crossref.org/works/10.1016/S1089-3261(05)70194-X

7 January 2021

10.1016/S1089-3261(05)70194-X

Identifiers

DOI

1 reference

1 August 2017

1 reference